Main page content

Displaying results 1 - 7 of 7
Publication ID: PEP22-06-04-003
Published:

This advisory introduces readers to Cannabidiol (CBD), how it is derived, how it differs from THC and other cannabinoids, the risks and harms of CBD use, and common misconceptions given its broad availability.

Publication ID: PEP20-02-02-016
Published:

This Advisory is based on TIP 39, Substance Use Disorder Treatment and Family Therapy. It surveys basic factors for programs and providers to consider when implementing family-related therapy approaches, goals and processes for conducting effective family counseling, and resources for further learning about family therapy techniques and models.

Publication ID: PEP20-02-01-017
Published:

This Advisory is based on Technical Assistance Publication (TAP) 21, Addiction Counseling Competencies: The Knowledge, Skills, and Attitudes of Professional Practice. It discusses the development of the counseling competencies and the validated research on which they are based, provides a simplified overview of their structure and the elements of a typical competency, and outlines how these competencies are changing the field of substance use disorder (SUD) treatment nationwide. The Advisory also addresses the critical role of cultural competency.

Publication ID: PEP20-02-01-020
Published:

Based on Treatment Improvement Protocol (TIP) 41, Substance Abuse Treatment: Group Therapy, this Advisory provides an overview of goals, processes, group-specific approaches, resources, and common elements that support favorable outcomes in group therapy.

Publication ID: PEP20-02-02-015
Published:

This Advisory, based on TIP 49, Incorporating Alcohol Pharmacotherapies Into Medical Practice, focuses on medication and related treatment decisions made after screening and assessment for AUD, and medically supervised withdrawal, if necessary. Alcohol consumption should not stop abruptly in those patients who have consumed alcohol regularly over a prolonged period of time. This Advisory is meant as an overview of AUD medications to facilitate abstinence.

Publication ID: SMA16-4938
Published:

This advisory summarizes data on the use of sublingual and transmucosal buprenorphine for the medication-assisted treatment of opioid use disorder.

Publication ID: SMA15-4925
Published:

This advisory defines attention deficit hyperactivity disorder in adults, and explains interactions with substance use disorders.